Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway
Novel strategies for overcoming multidrug resistance are urgently needed to improve chemotherapy success and reduce side effects. Ginsenosides, the main active components of <i>Panax ginseng</i>, display anti-cancer properties and reverse drug resistance; however, the biological pathways...
Main Authors: | Un-Jung Yun, In Hye Lee, Jae-Seon Lee, Jaegal Shim, Yong-Nyun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/3/605 |
Similar Items
-
Ginsenoside Rg3 Attenuates TNF-α-Induced Damage in Chondrocytes through Regulating SIRT1-Mediated Anti-Apoptotic and Anti-Inflammatory Mechanisms
by: Ching-Hou Ma, et al.
Published: (2021-12-01) -
Major ginsenosides from Panax ginseng promote aerobic cellular respiration and SIRT1-mediated mitochondrial biosynthesis in cardiomyocytes and neurons
by: Qingxia Huang, et al.
Published: (2022-11-01) -
Progress in the Conversion of Ginsenoside Rb1 into Minor Ginsenosides Using β-Glucosidases
by: Hongrong Zhu, et al.
Published: (2023-01-01) -
Ginsenosides Rc, as a novel SIRT6 activator, protects mice against high fat diet induced NAFLD
by: Zehong Yang, et al.
Published: (2023-05-01) -
Characterization of a Novel Ginsenoside MT1 Produced by an Enzymatic Transrhamnosylation of Protopanaxatriol-Type Ginsenosides Re
by: Byeong-Min Jeon, et al.
Published: (2020-03-01)